
Overview
Status
Active
Registry date
2002-02-13
Share capital
13,800,000.00 PLN
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 9 days early. All were audited by a statutory auditor.
- 202513/07/2026
- 202410/07/2025
- 202304/07/2024
- 202230/06/2023
- 202115/07/2022
- 202024/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Robert Mrzygłód – President of the Management Board
Manner of representation
Each member of the management board independently
Supervisory board
Andrzej Nędza – Supervisory Board Member
Elżbieta Bylica – Supervisory Board Member
Maria Janina Pytlik – Supervisory Board Member
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2002-02-01.
15 1910 1048 2102 0351 2652 0001
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
18 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| Mar 2, 2022 | Shareholders' meeting convened | |
| Aug 24, 2021 | Shareholders' meeting convened | |
| Dec 23, 2020 | Commercial Companies Code notice | |
| Dec 3, 2020 | Commercial Companies Code notice | |
| Nov 12, 2020 | Commercial Companies Code notice |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| Celon PharmaS.A. | $52,550,739.16 | celonpharma.com | ||
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A. | $37,103,878.54 | biomed.pl | ||
| Fagronsp. z o.o. | $21,715,187.73 | fagron.pl | ||
| Krakowskie Zakłady Zielarskie Herbapol w KrakowieS.A. | $7,294,338.51 | herbapol.krakow.pl | ||
| STEM Cells SpinS.A. | $287,714.76 | stemcellsspin.com.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Zakład Farmaceutyczny Amarasp. j. | $0.00 | amara.pl |
Change history
| Date | Event | |
|---|---|---|
| 2006-10-26 | Share capital increase (12,300,000.00 PLN → 13,800,000.00 PLN) | |
| 2006-02-01 | Share capital increase (11,000,000.00 PLN → 12,300,000.00 PLN) | |
| 2005-01-24 | Share capital increase (9,500,000.00 PLN → 11,000,000.00 PLN) | |
| 2004-10-28 | Share capital increase (7,700,000.00 PLN → 9,500,000.00 PLN) | |
| 2004-01-06 | Share capital increase (6,450,000.00 PLN → 7,700,000.00 PLN) |
FAQ
The main business activity of Biomar focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on February 13, 2002.
The headquarters is located at: Mogilska 40, 31-546 Kraków.
The management board consists of: Robert Mrzygłód (President of the Management Board).
The share capital of the company is PLN 13,800,000 (approx. $3.7 million).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-07-16